![Alfred Sandrock](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alfred Sandrock
Verkställande Direktör på
VOYAGER THERAPEUTICS, INC.
Förmögenhet: 2 M $ per 2026-05-31
Profil
Alfred W.
Sandrock is President, Chief Executive Officer & Director at Voyager Therapeutics, Inc. since 2022.
Holds the position of Chairman at PhRMA Foundation.
Serves as Director at Transition Bio, Inc. and Verge Analytics, Inc. since 2022.
Member of the American Academy of Neurology.
Professor at Harvard Medical School.
Advisor at Longwood Fund Management LLC.
Former Independent Director at Neurocrine Biosciences, Inc. from 2015 to 2020.
Former Director at FORUM Pharmaceuticals, Inc., Disarm Therapeutics, Inc. from 2017 to 2020, Atalanta Therapeutics, Inc. from 2022 to 2024, and Praxis Precision Medicines, Inc. Former Head of Research & Development at Biogen, Inc. from 2020 to 2021.
Former Chief Medical Officer at Biogen Idec, Inc. (North Carolina).
Education includes a doctorate from Harvard University in 1988, an undergraduate degree from Stanford University in 1979, and a doctorate from Harvard Medical School in 1988.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-02 | 472 549 ( 0,78 % ) | 2 M $ | 2026-05-31 |
Aktiva positioner av Alfred Sandrock
| Företag | Position | Start |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Verkställande Direktör | 2022-03-22 |
Transition Bio, Inc.
 Transition Bio, Inc. BiotechnologyHealth Technology Provides condensate technology for drug discovery and diagnostics | Direktör/Styrelseledamot | 2022-02-01 |
Verge Analytics, Inc.
 Verge Analytics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Direktör/Styrelseledamot | 2022-02-08 |
PhRMA Foundation
 PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Ordförande | - |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
American Academy of Neurology
 American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Företagsledare/Principal | - |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund invests in companies located in the United States. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Konsult / Rådgivare | - |
Tidigare kända positioner av Alfred Sandrock
| Företag | Position | Slut |
|---|---|---|
Atalanta Therapeutics, Inc.
 Atalanta Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops RNA interference based therapeutics to treat neurodegenerative diseases | Direktör/Styrelseledamot | 2024-09-01 |
| BIOGEN INC. | Teknisk/Vetenskaplig/F&U Direktör | 2021-12-31 |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Alfred Sandrocks utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
89
Första gradens relationer
16
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 16 |
|---|---|
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
FORUM Pharmaceuticals, Inc.
 FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for central nervous system disorders | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
American Academy of Neurology
American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Commercial Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Longwood Fund Management LLC
Longwood Fund Management LLC Investment ManagersFinance Longwood Fund invests in companies located in the United States. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Finance |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Commercial Services |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Verge Analytics, Inc.
Verge Analytics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Praxis Precision Medicines, Inc.
 Praxis Precision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders | Health Technology |
Disarm Therapeutics, Inc.
 Disarm Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat patients with neurological diseases | Health Technology |
Atalanta Therapeutics, Inc.
Atalanta Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops RNA interference based therapeutics to treat neurodegenerative diseases | Commercial Services |
Transition Bio, Inc.
Transition Bio, Inc. BiotechnologyHealth Technology Provides condensate technology for drug discovery and diagnostics | Health Technology |
